FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Top Story

E-therapeutics opens in-silico consultancy ops

A systems biology spin-off from Newcastle University has opened up a new consultancy division that will use its in-silico technology to assess the safety and efficacy of new drug candidates. E-therapeutics' technology assesses how a drug will respond to cells as well as other therapeutics. And the start-up has already lined up a lengthy list of drug partners, ranging from GlaxoSmithKline to Mylan Laboratories and Chakra Biotech. Read more...

Syndicate content

Latest News

Researchers flag new cancer therapy that guards p53

May 6, 2008
Scientists in Scotland say that they have identified a chemical group that can protect the p53 gene, a guardian against cancer tumors which is damaged or turned off in most cancer cases. They believe Read more...
Tags: tumors   Cancer   Enzymes   guardian  

Fat cell research points to new approach on obesity

May 6, 2008
Swedish researchers have concluded that the number of fat cells present in the body is a constant, remaining unchanged regardless of how much a person weighs or gains. Every year about 10 percent of Read more...
Tags: obesity   Diabetes  

Scientists forecasts use of stem cells to grow parts

May 6, 2008
UK cell biologist Robert Edwards says he can see a time in the not-too-distant future when humans will be able to grow new body parts through the use of stem cell technology. And the doctor, Read more...
Tags: Stem Cells   regenerative medicine   heart valves   heart  

ALSO NOTED: StemCyte to open NJ facility; Cornell researchers win million-dollar grant;

May 6, 2008
Stem Cell Research California's StemCyte will open a facility in New Jersey and hire 12 people to do stem cell research work. The company was drawn to the state with $589,000 in state grants. Read more...
Tags: Stem Cells   Shinya Yamanaka   Cancer   skin cells  

Chance discovery links ACE inhibitors to weight loss

April 29, 2008
Australian scientists say that targeting angiotensin converting enzyme (ACE) can be an effective way to spur weight loss and prevent diabetes. And the research demonstrates that ACE-inhibitors could Read more...
Tags: Scripps Research Institute   obesity  

Consortium uses 'virtual patients' to find drugs

April 29, 2008
Pfizer is providing $14.4 million to fund a research consortium involving four universities and Entelos, a company that does computer modeling for drug research work, in a drive to create a new class Read more...

Gene therapy helps improve sight of the blind

April 29, 2008
Two new human trials of a gene therapy for inherited blindness have demonstrated that injecting replacement genes under the retinas of the blind can spur at least partial sight in some volunteers. In Read more...
Tags: Targeted Genetics   genetics   blindness   guardian  

Counterpoint: An argument for industry-backed research

April 29, 2008
Management consultant Dr. David A. Shaywitz has joined with Dr. Dennis A. Ausiello, the physician-in-chief of Massachusetts General Hospital and a director at Pfizer, to deliver a rebuttal to a small Read more...
Tags: Pfizer  

More news